$404 Million is the total value of 5AM Venture Management, LLC's 21 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 10.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CINCOR PHARMA INC | $81,721,000 | +7.4% | 4,337,646 | 0.0% | 20.22% | +21.7% | ||
| ENTRADA THERAPEUTICS INC | $53,694,000 | +29.7% | 4,408,379 | 0.0% | 13.28% | +46.9% | ||
| VOR | VOR BIOPHARMA INC | $31,618,000 | -17.7% | 6,361,723 | 0.0% | 7.82% | -6.8% | |
| PEAR THERAPEUTICS INC | $28,693,000 | -69.5% | 18,631,771 | 0.0% | 7.10% | -65.5% | ||
| Sell | RALLYBIO CORP | $28,167,000 | +1.4% | 3,730,724 | -6.3% | 6.97% | +14.8% | |
| IMPL | IMPEL NEUROPHARMA INC | $26,886,000 | +46.3% | 2,884,791 | 0.0% | 6.65% | +65.7% | |
| AKUS | AKOUOS INC | $19,397,000 | -1.3% | 4,135,784 | 0.0% | 4.80% | +11.8% | |
| IDYA | IDEAYA BIOSCIENCES INC | $19,293,000 | +23.3% | 1,398,066 | 0.0% | 4.77% | +39.7% | |
| SCPH | Sell | SCPHARMACEUTICALS INC | $17,166,000 | -21.1% | 3,561,474 | -7.0% | 4.25% | -10.7% |
| ARVN | ARVINAS INC | $16,836,000 | -37.5% | 400,000 | 0.0% | 4.17% | -29.1% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $16,082,000 | -15.0% | 862,286 | 0.0% | 3.98% | -3.7% | |
| PHVS | New | PHARVARIS N V | $12,986,000 | – | 587,600 | +100.0% | 3.21% | – |
| COGT | Buy | COGENT BIOSCIENCES INC | $10,185,000 | +91.2% | 1,129,200 | +58.7% | 2.52% | +116.5% |
| ISEE | IVERIC BIO INC | $9,888,000 | -42.8% | 1,027,874 | 0.0% | 2.45% | -35.3% | |
| FIXX | HOMOLOGY MEDICINES INC | $8,936,000 | -35.2% | 4,535,919 | 0.0% | 2.21% | -26.6% | |
| RNA | AVIDITY BIOSCIENCES INC | $5,675,000 | -21.3% | 390,555 | 0.0% | 1.40% | -10.9% | |
| JANX | JANUX THERAPEUTICS INC | $5,449,000 | -14.8% | 446,266 | 0.0% | 1.35% | -3.6% | |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $5,148,000 | – | 182,370 | +100.0% | 1.27% | – |
| FVAM | 5 01 ACQUISITION CORP | $3,615,000 | +0.5% | 365,126 | 0.0% | 0.89% | +13.9% | |
| CABA | CABALETTA BIO INC | $2,188,000 | -47.8% | 2,064,263 | 0.0% | 0.54% | -40.9% | |
| CDTX | CIDARA THERAPEUTICS INC | $554,000 | -41.4% | 1,134,511 | 0.0% | 0.14% | -33.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
| ARVINAS INC | 16 | Q3 2023 | 14.3% |
| Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
| SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
| IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
| VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
| CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
| AKOUOS INC | 10 | Q3 2022 | 27.7% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.